FDA SUPPLEMENTAL USE REVIEW STREAMLINING ENDORSED BY DANA FARBER's CHABNER; AGENCY SHOULD PUBLICIZE CLINICAL TRIAL INFORMATION -- KIDNEY CANCER ASSOCIATION

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".